256 related articles for article (PubMed ID: 27304669)
1. Anti-arrhythmic Medication Propafenone a Potential Drug for Alzheimer's Disease Inhibiting Aggregation of Aβ: In Silico and in Vitro Studies.
Ngo ST; Fang ST; Huang SH; Chou CL; Huy PD; Li MS; Chen YC
J Chem Inf Model; 2016 Jul; 56(7):1344-56. PubMed ID: 27304669
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro characterization of anti-amyloidogenic activity of vitamin K3 analogues for Alzheimer's disease.
Huy PD; Yu YC; Ngo ST; Thao TV; Chen CP; Li MS; Chen YC
Biochim Biophys Acta; 2013 Apr; 1830(4):2960-9. PubMed ID: 23295971
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
6. Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.
Orjuela A; Lakey-Beitia J; Mojica-Flores R; Hegde ML; Lans I; Alí-Torres J; Rao KS
J Alzheimers Dis; 2021; 82(s1):S321-S333. PubMed ID: 33337368
[TBL] [Abstract][Full Text] [Related]
7. Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).
Dong M; Li H; Hu D; Zhao W; Zhu X; Ai H
ACS Chem Neurosci; 2016 May; 7(5):599-614. PubMed ID: 26871000
[TBL] [Abstract][Full Text] [Related]
8. Curcumin derivatives and Aβ-fibrillar aggregates: An interactions' study for diagnostic/therapeutic purposes in neurodegenerative diseases.
Orteca G; Tavanti F; Bednarikova Z; Gazova Z; Rigillo G; Imbriano C; Basile V; Asti M; Rigamonti L; Saladini M; Ferrari E; Menziani MC
Bioorg Med Chem; 2018 Aug; 26(14):4288-4300. PubMed ID: 30031653
[TBL] [Abstract][Full Text] [Related]
9. Anti-amyloidogenic and anti-apoptotic effect of α-bisabolol against Aβ induced neurotoxicity in PC12 cells.
Shanmuganathan B; Suryanarayanan V; Sathya S; Narenkumar M; Singh SK; Ruckmani K; Pandima Devi K
Eur J Med Chem; 2018 Jan; 143():1196-1207. PubMed ID: 29150331
[TBL] [Abstract][Full Text] [Related]
10. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.
Khambete MP; Khare LP; Kapadia AB; Degani MS
Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32776895
[TBL] [Abstract][Full Text] [Related]
11. Multi-functional activities of citrus flavonoid narirutin in Alzheimer's disease therapeutics: An integrated screening approach and in vitro validation.
Chakraborty S; Basu S
Int J Biol Macromol; 2017 Oct; 103():733-743. PubMed ID: 28528948
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin.
Yan J; Hu J; Liu A; He L; Li X; Wei H
Bioorg Med Chem; 2017 Jun; 25(12):2946-2955. PubMed ID: 28454848
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway.
Thapa A; Jett SD; Chi EY
ACS Chem Neurosci; 2016 Jan; 7(1):56-68. PubMed ID: 26529184
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.
Kundaikar HS; Degani MS
Chem Biol Drug Des; 2015 Oct; 86(4):805-12. PubMed ID: 25763767
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study.
Doytchinova I; Atanasova M; Salamanova E; Ivanov S; Dimitrov I
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942739
[TBL] [Abstract][Full Text] [Related]
17. A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease.
Rivera-Marrero S; Bencomo-Martínez A; Orta Salazar E; Sablón-Carrazana M; García-Pupo L; Zoppolo F; Arredondo F; Dapueto R; Daniela Santi M; Kreimerman I; Pardo T; Reyes L; Galán L; León-Chaviano S; Espinosa-Rodríguez LA; Menéndez-Soto Del Valle R; Savio E; Díaz Cintra S; Rodríguez-Tanty C
Bioorg Med Chem; 2020 Oct; 28(20):115700. PubMed ID: 33069076
[TBL] [Abstract][Full Text] [Related]
18. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity?
Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT
J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
